Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

Injectable Contraceptives May Increase the Risk of Developing Brain Tumors

New research reveals that a popular family of drugs used for contraception and menopausal treatment could be linked to certain brain tumors.

Credit: Anukool Manoton/Shutterstock

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

For people going through menopause or seeking birth control options, medications that help replace and supplement key sex hormones — known as progestogens — are an essential part of treatment.

However, new research published last month suggests that these types of medications are associated with higher risk of a common type of brain tumor. Now, scientists are urging caution and pursuing further research on progestogens as a form of contraception and gynecological treatment.

Progestogens are a family of medications that mimic the effects of progesterone, a sex hormone produced in the ovaries. These medications are used to treat menopausal symptoms and endometriosis, and are one of the most widely-used forms of contraception globally.

Read More: An Accurate History of Birth Control: How Long Have Humans Used It?

Yet a 2014 study found that progesterone receptors are also found in most meningiomas — a type of tumor, usually benign, that grows ...

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles